Su-Bin Choi

Title: Su-Bin Choi: Innovator in Pharmaceutical Chemistry

Introduction

Su-Bin Choi is a notable inventor based in Yongin-si, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on quinazoline derivatives. Her research focuses on developing compounds that can effectively combat cancer while minimizing adverse side effects.

Latest Patents

Su-Bin Choi holds a patent for a quinazoline derivative or its salt, along with a pharmaceutical composition comprising the same. This invention provides a selective inhibitory activity against the phosphatidylinositol 3-kinase delta subunit. The implications of her work are profound, as it offers potential applications for preventing or treating cancer while avoiding side effects such as lymphopenia-associated inflammatory responses. She has 1 patent to her name.

Career Highlights

Choi is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. Her role at Yuhan Corporation allows her to further her research and contribute to the development of innovative therapeutic solutions.

Collaborations

Throughout her career, Su-Bin Choi has collaborated with esteemed colleagues, including Young-hwan Kim and Tae-Dong Han. These partnerships have enhanced her research efforts and expanded the impact of her inventions.

Conclusion

Su-Bin Choi is a pioneering inventor whose work in pharmaceutical chemistry is making strides in cancer treatment. Her innovative approach to developing quinazoline derivatives showcases her commitment to advancing medical science.